Massachusetts voters decisively shot down a ballot initiative that would have dismantled the state’s recreational cannabis ...

MAHA was already fracturing over issues like pesticides, and factored little into key races.  Now it must contend with a big ...

WASHINGTON — Democrats broke the Republican trifecta of power in Washington Tuesday night, securing powerful new tools to ...

Democratic physicians, nurses, and scientists won dramatic victories across the U.S. on Tuesday, part of the sweeping blue ...

This is the web edition of STAT’s AI Prognosis newsletter, our guide to artificial intelligence in health care and medicine.

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter ...

The FDA gave tentative approval to Dr. Reddy’s Laboratories to make a generic version of a groundbreaking HIV prevention ...

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and ...

WASHINGTON — Ever since the Treasury Department proposed to limit U.S. investment in the Chinese biotech industry last week, ...

A person in Washington state has died from complications of the bird flu, the first such U.S. death in a year.

Officials are moving behind the scenes to head off a conflict brewing between states and the federal government over ...